Skip to Content

APO TP 25 (Topiramate 25 mg)

Pill imprint APO TP 25 has been identified as Topiramate 25 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate 25 mg APO TP 25
Topiramate 25 mg APO TP 25
Discount Card Promo
Topiramate
Imprint:
APO TP 25
Strength:
25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-2760
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
magnesium stearate
methylcellulose (15 mPa.s)
polyethylene glycol 8000
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60429-0769 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide